2 Pharma stocks in focus after receiving Government and export orders worth ₹38 Cr

Synopsis: Two pharma stocks announced fresh order wins, with Medico Remedies securing a Rs. 37.18 crore government contract from UPMSCL, while Shelter Pharma bagged a USD 103,950 export order from Sudan, improving revenue visibility.

The first pharma company is a pharmaceutical formulations manufacturer focusing on anti-infectives, beta-lactams, cephalosporins, antimalarials, antiretrovirals, gastrointestinal drugs, vitamins, haematinics, and nutritional supplement is now in focus after securing a government supply order worth Rs. 37.18 crore from Uttar Pradesh Medical Supplies Corporation Limited (UPMSCL).

The second pharma company is a leading pharmaceutical and nutraceutical company known for its unwavering dedication to research, innovation, and quality is also in focus after securing an international export order worth from Taha Drugs & Chemicals Co. Ltd, Sudan.

Medico Remedies Ltd

With a market capitalisation of Rs. 425 cr, the shares of Medico Remedies Ltd are currently trading at Rs. 51.31 per share, down by 4% from its previous close of Rs. 53.53 per share.

Medico Remedies Limited has secured a government supply order worth Rs. 37.18 crore from Uttar Pradesh Medical Supplies Corporation Limited (UPMSCL), an entity formed by the Government of Uttar Pradesh. The order involves the supply of multiple pharmaceutical drugs and will be executed by 31 October 2026.

This is a domestic government contract, awarded on standard contractual terms. UPMSCL is responsible for the centralised procurement and distribution of medicines for public healthcare services across Uttar Pradesh.

Medico Remedies Limited is a pharmaceutical formulation manufacturer with strong manufacturing and marketing capabilities. It focuses on anti-infectives, beta-lactams, cephalosporins, antimalarials, antiretrovirals, gastrointestinal drugs, vitamins, and supplements, along with a diversified portfolio covering cardiovascular, anti-diabetic, CNS, NSAIDs, syrups, and topical formulations.

Shelter Pharma Ltd

With a market capitalisation of Rs. 62 cr, the shares of Shelter Pharma Ltd have last traded at Rs. 38 per share, down from its previous close of Rs. 38.90 per share. Shelter Pharma Limited has informed that it has secured an international export order worth USD 103,950 (approx Rs. 95 lakhs) from Taha Drugs & Chemicals Co. Ltd, Sudan. The order is for the supply of All Vitamins Tablets (3×10 strips per box) 

The contract is a fixed-cost order awarded by an international entity, marking Shelter Pharma’s continued presence in global pharmaceutical markets. The company is expected to execute the order within two months, providing near-term revenue visibility.

Shelter Pharma Limited is a leading pharmaceutical and nutraceutical company known for its unwavering dedication to research, innovation, and quality. Founded with a vision to provide accessible and effective healthcare solutions, we have consistently delivered products that adhere to the highest industry standards. 

Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Trade Brains Technologies Private Limited or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.

The post 2 Pharma stocks in focus after receiving Government and export orders worth ₹38 Cr appeared first on Trade Brains.